New search:
If you are not happy with the results below please do another search
July 2025 LabCoP Extended ECHO Session: Practical Approaches to tNGS Implementation for Rapid Detection of Drug-Resistant TB: Insights from West Java, Indonesia
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
June 2025 LabCoP Extended ECHO session: Making Genomics Work for TB: Practical and Cost-Effective Use of tNGS in TB Programs
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
LabCop ECHO SEssion Summary July–Sept 2025
During the 3rd quarter of 2025, the Laboratory Systems Strengthening Community of Practice (LabCoP), with support from the Gates Foundation and partner organizations, convened seve
Lab Lessons from the Frontlines: April–June 2025 in Review
Between April and June 2025, the Laboratory Systems Strengthening Community of Practice (LabCoP), with support from the Gates Foundation and partner organizations, convened ten imp
June 2025 LabCoP Extended ECHO Session: Flying blind: the urgent need for rapid detection of bedaquiline-resistant TB
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a